Showing posts with label Adlyxin (lixisenatide) for Treatment of Adults With Type 2 Diabetes. Show all posts
Showing posts with label Adlyxin (lixisenatide) for Treatment of Adults With Type 2 Diabetes. Show all posts
Tuesday, May 2, 2017

Sanofi Receives FDA Approval of Adlyxin (lixisenatide) for Treatment of Adults With Type 2 Diabetes

›
Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Adlyxin ( lixisenatide) , a once-daily mealtime GLP-1 rec...